Target niche Private clinical research site network focused on non-alcoholic fatty liver disease and cirrhosis in the Rio Grande Valley, presenting a ready-made regional partner for sponsors seeking NAFLD/Cirrhosis trials with access to patient populations in Edinburg and Brownsville.

Growth potential Mid-market scale with 11-50 employees and revenue in the 1M-10M band, indicating a nimble partner capable of handling multi-site studies or early-phase trials while offering agility and potentially favorable CRO-like collaboration terms.

Tech stack leverage Investments in modern digital tooling (Google Cloud, PWA, Appsflyer, Google Ads, Facebook Pixel) enable streamlined patient recruitment, data capture, and performance tracking, which can be highlighted to sponsors prioritizing analytics-driven study execution.

Regional focus Strategic advantage as a dedicated South Texas regional hub for NAFLD research, enabling sponsors to access underserved patient populations and site networks within the Rio Grande Valley to diversify trial sites or fulfill regulatory geography requirements.

Strategic fit Complementary to larger academic centers in Texas, STRI offers potential collaboration opportunities for sponsor-funded trials, site expansion projects, or co-development ventures leveraging existing relationships with local patient communities and streamlined operations.